Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

62,201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive genomic profiling of combined small cell lung cancer.
Zhang J, Zhang L, Luo J, Ge T, Fan P, Sun L, Hou L, Li J, Yu H, Wu C, Zhu Y, Wu C, Jiang G, Troncone G, Malhotra J, Okuda K, Santarpia M, Zamarchi R, Goto T, Cardona AF, Xu J, Chen Q, Zhang Z, Zhang P; written on behalf of the AME Lung Cancer Collaborative Group. Zhang J, et al. Among authors: xu j. Transl Lung Cancer Res. 2021 Feb;10(2):636-650. doi: 10.21037/tlcr-20-1099. Transl Lung Cancer Res. 2021. PMID: 33718010 Free PMC article.
Identification and evaluation of circulating small extracellular vesicle microRNAs as diagnostic biomarkers for patients with indeterminate pulmonary nodules.
Zheng D, Zhu Y, Zhang J, Zhang W, Wang H, Chen H, Wu C, Ni J, Xu X, Nian B, Chen S, Wang B, Li X, Zhang Y, Zhang J, Zhong W, Xiong L, Li F, Zhang D, Xu J, Jiang G. Zheng D, et al. Among authors: xu x, xu j. J Nanobiotechnology. 2022 Apr 2;20(1):172. doi: 10.1186/s12951-022-01366-0. J Nanobiotechnology. 2022. PMID: 35366907 Free PMC article.
EGFR G796D mutation mediates resistance to osimertinib.
Zheng D, Hu M, Bai Y, Zhu X, Lu X, Wu C, Wang J, Liu L, Wang Z, Ni J, Yang Z, Xu J. Zheng D, et al. Among authors: xu j. Oncotarget. 2017 Jul 25;8(30):49671-49679. doi: 10.18632/oncotarget.17913. Oncotarget. 2017. PMID: 28572531 Free PMC article.
Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials.
Gao G, Ren S, Li A, Xu J, Xu Q, Su C, Guo J, Deng Q, Zhou C. Gao G, et al. Among authors: xu q, xu j. Int J Cancer. 2012 Sep 1;131(5):E822-9. doi: 10.1002/ijc.27396. Epub 2012 Jan 27. Int J Cancer. 2012. PMID: 22161771 Free article.
62,201 results
You have reached the last available page of results. Please see the User Guide for more information.